# Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients

> **NCT06272227** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 340 (estimated)

## Conditions studied

- Sarcopenia

## Interventions

- **DRUG:** alfacalcidol
- **DRUG:** placebo
- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT06272227
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-13
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06272227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06272227, "Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06272227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*